Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma
Journal of Oncology · 06.10.2022 · 2022 · 1-23
DOI: 10.1155/2022/5005747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology, erschienen am 06.10.2022. Verfasst von Qin Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic Research and Frontier Exploration Project of Chongqing and Technology Commission, Chongqing Medical University.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is one of the leading malignant carcinomas. Despite the advancement in the treatment for HCC, such as precise hepatectomy, radiotherapy, transarterial therapies, chemotherapy, targeted treatments, and immunotherapy, the 5-year overall survival rate of HCC is extremely low. Hence, novel biomarkers are urgently needed for advancing the therapy and prognosis of HCC. Neurexophilin 4 (NXPH4) is a neuropeptide-like glycoprotein. The study is designed to investigate the function of NXPH4 in HCC through a comprehensive bioinformatics analysis. NXPH4 expression status and prognostic values were analyzed via multiple datasets, such as TCGA, GEO, and ICGC. The association between NXPH4 and immune cell infiltration was estimated by TIMER, TISIDB, and CIBERSORT. In vitro, we explored the biological function of NXPH4 in JHH7 and SNU182 cells through knocking down the expression of NXPH4 via siRNA. In general, NXPH4 was predominantly upregulated in HCC tumors, and increased NXPH4 expression predicted unfavorable prognosis. The gene enrichment analysis displayed that NXPH4 was related with metabolic pathways. NXPH4 expression was correlated with immune cell infiltration. NXPH4 knockdown significantly suppressed proliferation, migration, and invasion of JHH7 and SNU182 cells. This study suggested that the upregulation of NXPH4 is associated with adverse prognosis and immune cell infiltration in HCC. NXPH4 could be a novel biomarker of unfavorable prognosis and an underlying target for immunotherapy in HCC.
Autor:innen und Institutionen
- Department of Gastroenterology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
- Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
- Bashu Secondary School, Chongqing, China.
- Chongqing Medical University, Chongqing, China.
Förderung
- National Natural Science Foundation of China
- Basic Research and Frontier Exploration Project of Chongqing and Technology Commission
- Chongqing Medical University
Zitieren
APA
Tang, Q., Chen, Y. M., Shen, M. M., Dai, W., Liang, H., Liu, J. N., & Gao, J. (2022). Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma. Journal of Oncology, 2022, 1-23. https://doi.org/10.1155/2022/5005747
Vancouver
Tang Q, Chen YM, Shen MM, Dai W, Liang H, Liu JN, et al. Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma. Journal of Oncology. 2022;2022:1-23. doi:10.1155/2022/5005747
BibTeX
@article{Tang2022,
author = {Tang, Qin and Chen, Yue-Ming and Shen, Mei-Mei and Dai, Wen and Liang, Hang and Liu, Jun-Nan and Gao, Jian},
title = {Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma},
journal = {Journal of Oncology},
year = {2022},
volume = {2022},
pages = {1--23},
doi = {10.1155/2022/5005747}
}
EUVIMED